Status | Study |
Recruiting |
Study Name: Fatty Acid Oxidation Defects and Insulin Sensitivity Condition: Very Long-chain Acyl-CoA Dehydrogenase Deficiency Trifunctional Protei Date: 2015-07-02 Interventions: Drug: Intralipid/Heparin Co-in |
Completed |
Study Name: High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders Condition: Very Long-chain Acyl-CoA Dehydrogenase Deficiency Trifunctional Protei Date: 2011-12-14 Interventions: Behavioral: Diet counseling Subjects counseled how to follow either the high carbohydrate diet or the hi |
Available |
Study Name: Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism Condition: Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency Carnitine Palmitoyltransferase Defi Date: 2011-10-25 Interventions: Drug: triheptanoin subjects will receive a modified diet containing triheptanoin (up to 2 grams/kg/24 ho |
Terminated |
Study Name: Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy Condition: Peripheral Neuropathy Mitochondrial Trifunctional Protein Deficiency Date: 2009-02-09 Interventions: Dietary Supplement: Vitamin E supplement 400 IU (268 mg) capsules of will be provided for the subjects. |
Completed |
Study Name: Fatty Acid Oxidation Disorders & Body Weight Regulation Grant Condition: Trifunctional Protein Deficiency Date: 2008-04-03 |